Phase Ib study of the oral PI3Kδ inhibitor linperlisib in patients with advanced solid tumors.
Li J, Xue J, Liu T, Feng Y, Xu N, Huang J, Yin Y, Zhang J, Mou H, Shentu J, Bao H, Xu Z, Xu Z.
Li J, et al. Among authors: xu n.
Int J Clin Oncol. 2024 Nov 13. doi: 10.1007/s10147-024-02657-2. Online ahead of print.
Int J Clin Oncol. 2024.
PMID: 39538003